A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

NCT03529773 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1235

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Tract Infections

Interventions

BIOLOGICAL: Formulation A
BIOLOGICAL: Formulation B
BIOLOGICAL: Placebo

Sponsor

Pfizer